Get started
Author

Victor Simmet

Observed names: V. SIMMET, V. Simmet, V., Simmet, Victor SIMMET
ORCID: 0000-0001-6657-8989
Observed ORCID: 0000-0001-6657-8989
OpenAlex ID: A5040514205
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
2022 · Benoit Rousseau, Ivan Bieche, et al. · Cancer Discovery · 95
PDF
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025 · Caroline Abadie, Aldja Abderrahmane, et al. · The Lancet Regional Health - Europe · 69
PDF
Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
2021 · Jean-Luc Raoul, Catherine Guérin-Charbonnel, et al. · JAMA Network Open · 49
PDF
Chemotherapy of metastatic hepatoid adenocarcinoma: Literature review and two case reports with cisplatin etoposide
2017 · Victor Simmet, Margot Noblecourt, et al. · Oncology Letters · 36
PDF
526O High activity of nivolumab in patients with pathogenic exonucleasic domain POLE (edPOLE) mutated Mismatch Repair proficient (MMRp) advanced tumours
2020 · B.J-C. Rousseau, I. Bieche, et al. · Annals of Oncology · 33
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
2025 · Etienne Brain, Olivier Mir, et al. · The Lancet · 24
Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper
2022 · Jean-Luc Raoul, Julien Edeline, et al. · Cancers · 24
PDF
Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?
2019 · V. Simmet, L. Eberst, et al. · Annals of Oncology · 18
Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers
2023 · François Bocquet, Judith Raimbourg, et al. · International Journal of Environmental Research and Public Health · 8
PDF
Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial.
2022 · Antoine Adenis, Samuel Le Sourd, et al. · Journal of Clinical Oncology · 5
TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab vs best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum.
2023 · Alexandra Leary, Laurence Gladieff, et al. · Journal of Clinical Oncology · 3
1680P Feasibility of home-based supervised physical activity (SPA) for metastatic cancer patients receiving oral targeted therapy: The AFSOS-Unicancer QUALIOR randomized phase II study
2021 · F. Joly Lobbedez, C. Lefeuvre-Plesse, et al. · Annals of Oncology · 3
PDF
Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.
2023 · Antoine Adenis, Guillaume Piessen, et al. · Journal of Clinical Oncology · 2
PDF
EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RAS Metastatic Colorectal Cancer: A Randomized Phase II Study With Circulating Tumor Cell Analysis
2026 · Victor Simmet, Astrid Lièvre, et al. · Clinical Colorectal Cancer · 1
Biomarker selection for patients participating in phase I clinical trials.
2018 · Lauriane Eberst, Clemence Basse, et al. · Journal of Clinical Oncology · 1
Surgery after neoadjuvant chemotherapy for synchronous and exclusive peritoneal metastasis from colorectal cancer: a descriptive retrospective cohort study
2026 · Juliette Dubois, Elodie Martin, et al. · Surgical Oncology
Supplementary Material for: Prolonged survival in metastatic pancreatic acinar cell carcinoma treated with hepatic arterial infusion of oxaliplatin: a case report with longitudinal molecular profiling
2026 · karger, figshare admin, J., Dubois, et al. · Figshare
Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Treated with Hepatic Arterial Infusion of Oxaliplatin: A Case Report with Longitudinal Molecular Profiling
2026 · Juliette Dubois, Mehdi Kaassis, et al. · Case Reports in Oncology
PDF
Abstract PS1-12-29: Real-world outcomes of second-line therapies in HR+/HER2- metastatic breast cancer after progression on CDK4/6 inhibitor
2026 · A. PEINOIT, F. LE BORGNE, et al. · Clinical Cancer Research
Neoadjuvant chemotherapy for colorectal cancer with synchronous and exclusive peritoneal metastasis: A comprehensive retrospective cohort study.
2026 · Juliette Dubois, Elodie Martin, et al. · Journal of Clinical Oncology
PDF
Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study
2025 · Florence Joly, Claudia Lefeuvre-Plesse, et al. · The Oncologist
PDF
Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
2023 · Benoit Rousseau, Ivan Bieche, et al.
Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
2023 · Benoit Rousseau, Ivan Bieche, et al.
Supplementary Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
2023 · Benoit Rousseau, Ivan Bieche, et al.
Supplementary Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
2023 · Benoit Rousseau, Ivan Bieche, et al.
Works count: 30
Citation count: 371
H-index: 8
I10-index: 8
Year
Topic
Type